Correction Manuel Management - Vuibert
OBJECTIVE: Compare the efficacy and adverse effects of CDB-2914 [NDLR : CDB-2914 = ulipristal], a new progesterone receptor modulator, to levonorgestrel for.
OBJECTIVE: Compare the efficacy and adverse effects of CDB-2914 [NDLR : CDB-2914 = ulipristal], a new progesterone receptor modulator, to levonorgestrel for.